Published in Blood Weekly, September 30th, 2004
The basic term of the patent will expire in September 2019. Patents covering this technology are pending in other major markets, including Europe, Japan and Canada and have been issued in Australia and Singapore earlier this year.
The patent is a part of an intellectual property portfolio co.don AG has acquired some time ago. It builds the base for expanding the company's tissue engineering technologies into the area of cardiovascular...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.